Biomarker for Rheumatic Heart Disease (RHD)- Prototype is Ready for Commercialization | India Science, Technology & Innovation - ISTI Portal

×

Acces sibility Controls

Biomarker for Rheumatic Heart Disease (RHD)- Prototype is Ready for Commercialization

Implementing Organization

Indian Institute of Chemical Engineers

Indian Institute of Chemical Biology (IICB)

About

It is a protein based biomarker, it is detected in serum and urine, This test kit would help measurement of clinical activity in quiescent rheumatic heart disease, post penicillin treatment and overall management of the disease.

Patent Details

IN319303, ZA201302538

Related Research

Quick Information

Area of Research

Medical Sciences

Focus Area

Rheumatic Heart Disease

Status

completed

Patent No.

IN319303, ZA201302538

Output in Numbers

Research Paper

00

Technologies (If Any)

00

PhD Produced

N/A

Startup (If Any)

00

Patents

Filed :01

Grant :00